Professional Documents
Culture Documents
Antigen Processing
Click to edit Master subtitle style
That T and B cells recognise antigen differently The experimental evidence that antigen catabolism takes place Antigen processing generates antigenic peptides That antigen processing can take place in lysosomes That there is a non-lysosomal mechanism of antigen processing which the
The mechanism of antigen processing depends upon the compartment in pathogen replicates
The role of invariant chain HLA-DM and CLIP in antigen processing The role of the proteasome and transporters in antigen processing How pathogens evade immunity by disrupting antigen processing
YY
Cross-linking of surface membrane Ig
Y Y Y Y YY YY
Proliferation and antibody production
B B B B BB B B
Y Y Y Y Y Y
Y
Soluble native Ag Cell surface native Ag Soluble peptide s of Ag Cell surface peptides of Ag
ANTIGEN PROCESSING No T cell response No T cell response No T cell response No T cell response
T cell response
M
Macrophages and radiolabelled Listeria monocytogenes
M
Rapid binding to cell surface
M
Internalisation
Degradation of bacteria and release of Radiolabelled protein into supernatant and cells
The interaction of T cells with macrophages requires antigen catabolism Listeriaspecific T cells NO T CELLS BIND
T
NO T CELLS BIND M NO T CELLS BIND M
Listeria
NO T CELLS BIND M
0mins
T CELLS BIND M
60mins
T cell do not bind stably to antigen presenting cells unless the antigen is catabolised
M
Pulse with Listeria for 60min & wash cells
M
Add Listeria specific T cells NO T CELLS BIND
Determinants recognised by T cells are generated by catabolic activity that is dependent upon the viability of macrophages Antigen presenting cells must be viable to PROCESS antigen
Listeria
M
Fix with paraformaldehyde or poison with sodium azide
T M
Listeri a M
M
NO T CELLS BIND
Chloroquine inhibits lysosomal function (a lysosomotrophic drug) Antigen processing involves the lysosomal system
What form of antigen is produced by antigen processing? T Ovalbumin specific T cell line Native Digested ovalbumin ovalbumin
Ag
APC
AP C Viabl e
AP C Fixe d
T
AP C Viabl e
T T T T T
AP C Fixe d
T cell response
T T T T T
T T T T T
Most cell types do not have lysosomal systems developed as well as macrophages BUT Viruses can infect most cell types
Infectious viruses raise CTL that recognise antigens that are not generated by the exogenous pathway Infectious influenza
Strong T cell response
CT L CT L CT L CT L CT L
Cloned antiCTL
CT CT CT CT CT LCT L CT L CT LCT L CT L L CT L L L L
Kill
Lysosome inhibitors do not inhibit the generation of antigens recognised by most CTL Most CTL do not recognise lysosomally-derived antigens
Inactive viruses raise CTL to antigens that are generated by the exogenous pathway Inactivated influenza Weak T cell response Cloned antiCTL
CT L CT CT CT CT CT LCT L CT L CT LCT L CT L L CT L L L L
No Kill
Lysosomal inhibitors inhibit the generation of antigens from INACTIVE virus Some CTL can recognise lysosomally-derived antigens
Non-lysosomal processing
The antigens of infectious & inactivated viruses are clearly generated by different mechanisms Infectious viruses use cellular protein synthesis machinery to replicate Inactivated viruses do not synthesise protein
CT L
CT L
Untreate d Protein synthesis inhibitorProtein synthesis is required for treated virus infected target cells to express
antigens recognised by CTL
Influenza virus
CT L
Nucleoprotei n
CT L
Peptides of nucleoprotein
CT L
Synthetic peptide antigens sensitise targets for lysis No protein/antigen synthesis but peptides are pre-formed
The site of pathogen replication or mechanism of antigen uptake determines the antigen processing pathway used
Distinct mechanisms of antigen generation are used to raise T cells suited to the elimination of endogenous or exogenous pathogens
Antigens generated by endogenous and exogenous antigen processing activate different effector functions
Antibodies and phagocyte activation by T helper cells that use antigens generated by EXOGENOUS PROCESSING
Y
ENDOGENOUS PATHOGENS Eliminated by:
Killing of infected cells by CTL that use antigens generated by ENDOGENOUS PROCESSING
Y
Y
Phagocytosis
Pinocytosis
Uptake mechanisms direct antigen into intracellular vesicles for exogenous antigen processing
10 0 7 5 5 0 2 5 0
103
1010Antigen gml-1 2 1
Exogenous pathway
Cell surface Uptak e
Endosome s
Increas e in acidity
To lysosomes
Cathepsin B, D and L proteases are activated by the decrease in pH Proteases produce ~24 amino acid long peptides from antigens Drugs that raise the pH of endosomes inhibit antigen processing
Loss of the pro-region exposes the catalytic site of the protease At higher pH cathepsin B exists Acidification of the endosome alters the in a pro-enzyme form conformation of the proenzyme to allow cleavage of the pro-region Hence: drugs that alter acidification of the endosomes disturb exogenous antigen processing
Exogenous pathway
Cell surface Uptak e
Endosome s
Increas e in acidity
To lysosomes
Cathepsin B, D and L proteases are activated by the decrease in pH Proteases produce ~24 amino acid long peptides from antigens Drugs that raise the pH of endosomes inhibit antigen processing
Flopp Compac y t Although this example shows MHC class I molecules, the flexibility in the peptide binding
site of MHC class II molecules also occurs at an early stage of maturation in the endoplasmic reticulum
Need to prevent newly synthesised, unfolded self proteins from binding to immature MHC
Invariant chain stabilises MHC class II by non- covalently binding to the immature MHC class II molecule and forming a nonomeric complex
Three extended peptides each bind into the grooves of three MHC class II molecules to form the nonomeric complex
and
CLI P
A peptide of the invariant chain blocks the MHC molecule binding site. This peptide is called the CLass II associated Invariant chain Peptide (CLIP)
Uptak e
Removal of CLIP
How can the peptide stably bind to a floppy binding site? Competition between large number of peptides
HLADM
HLADR
HLA-DM: Crystallised without a peptide in the groove In space filling models the groove is very small
HLADM
Single pocket in groove insufficient to accommodate a peptide
HLADR
Multiple pockets in groove sufficient to accommodate a peptide
HLADR
MIIC compartment
The components of the proteasome include MECL-1, LMP2, LMP7 These components are induced by IFN- and replace constitutive components to confer proteolytic properties. LMP2 & 7 encoded in the MHC Proteasome cleaves proteins after hydrophobic and basic amino acids and releases peptides into the cytoplasm
View End on
Peptide antigens produced in the cytoplasm are physically separated from newly formed MHC class I
CYTOSOL
Peptides need access to the ER in order to be loaded onto MHC class I molecules
Lumen of ER
Peptide
ER membrane Cytosol
TAP-1 TAP-1 TAP-1 Peptide Peptide TAP-2 TAP-2 TAP-2
ATP-binding Peptide cassette antigens (ABC) domain from Transporter proteasomefor >8 amino acid peptides has preference
with hydrophobic C termini.
X
Transfection of normal TAP genes into mutant APC restored stable surface MHC class I expression
Chemically-induced mutant antigen presenting cell line with unstable (floppy) MHC class I expressed intracellularly
Mutations in TAP genes affect the supply of peptides to the ER MHC class I stability is dependent upon a supply of peptides
Peptide Peptide
Endoplasmic reticulum
Calnexin binds to nascent class I chain until 2-M binds B2-M binds and stabilises floppy MHC Tapasin, calreticulin, TAP 1 & 2 form a complex with the floppy MHC Cytoplasmic peptides are loaded onto the MHC molecule and the structure becomes compact
Peptide
Normally exported to the cell surface Adenoviral protein retains MHC class I in the ER
Summary
T and B cells recognise antigen differently Antigen must be catabolised before T cells can recognise it Antigen processing generates antigenic peptides Exogenous antigen processing takes place in lysosomes Endogenous processing is non-lysosomal The mechanism of antigen processing depends upon the compartment in which the pathogen replicates Endogenous and exogenous antigen processing both involve uptake, degradation, complex formation and presentation Exogenous antigen processing uses invariant chain and HLA-DM Endogenous antigen processing uses proteasomes and peptide transporters in antigen processing Pathogens can evade immunity by disrupting antigen processing